We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

182 hedge funds and large institutions have $2.6B invested in Medicines Co in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 21

29% more call options, than puts

Call options by funds: $11.1M | Put options by funds: $8.59M

6% more capital invested

Capital invested by funds: $2.46B → $2.6B (+$148M)

6% more funds holding

Funds holding: 172 → 182 (+10)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 66

Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
5.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
64
Reduced
66
Closed
21
Calls
$11.1M
Puts
$8.59M
Net Calls
+$2.52M
Net Calls Change
-$10.6M

Top Buyers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
+$32.2M
2
BM
Bridger Management
New York
+$22.5M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$16.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.9M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$51.8M
2
ZDA
Zweig-DiMenna Associates
New York
-$21.6M
3
Citadel Advisors
Citadel Advisors
Florida
-$12.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.1M
5
PHS
PFM Health Sciences
California
-$8.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
51
BlackRock Investment Management
Delaware
$8.05M -$61.3K -1,715 -0.8%
CM
52
Castleark Management
Illinois
$7.9M +$7.31M +204,445 New
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$7.7M +$372K +10,400 +6%
NFA
54
Nationwide Fund Advisors
Ohio
$7.7M +$2.9M +81,084 +69%
Barclays
55
Barclays
United Kingdom
$7.52M +$4.04M +113,053 +133%
TC
56
TFS Capital
Pennsylvania
$7.47M -$1.22M -33,992 -15%
CCM
57
Cadence Capital Management
Massachusetts
$7.37M -$5.11M -142,814 -43%
GC
58
Guggenheim Capital
Illinois
$6.72M -$306K -8,568 -5%
Charles Schwab
59
Charles Schwab
California
$6.61M +$330K +9,242 +6%
MSA
60
Mason Street Advisors
Wisconsin
$6.26M +$35K +978 +0.6%
Public Sector Pension Investment Board (PSP Investments)
61
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$6.01M +$190K +5,300 +4%
MACM
62
March Altus Capital Management
Connecticut
$5.9M +$5.46M +152,809 New
Prudential Financial
63
Prudential Financial
New Jersey
$5.6M +$99.4K +2,780 +2%
Wells Fargo
64
Wells Fargo
California
$5.54M +$1.19M +33,197 +30%
TD Asset Management
65
TD Asset Management
Ontario, Canada
$5.51M +$193K +5,400 +4%
AllianceBernstein
66
AllianceBernstein
Tennessee
$5.11M -$286 -8 -0%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$4.42M +$32.2K +900 +0.8%
HSA
68
Hussman Strategic Advisors
Maryland
$4.02M – – –
PIM
69
Partner Investment Management
California
$4.01M -$692K -19,361 -16%
PAMU
70
Pictet Asset Management (UK)
United Kingdom
$3.97M -$1.26M -35,300 -26%
CCMH
71
Cornerstone Capital Management Holdings
New York
$3.96M +$1.37M +38,300 +60%
NLGIA
72
Nippon Life Global Investors Americas
New York
$3.96M +$418K +11,680 +13%
BG
73
BlackRock Group
United Kingdom
$3.68M +$338K +9,447 +11%
DCM
74
Decatur Capital Management
Georgia
$3.68M +$154K +4,300 +5%
Macquarie Group
75
Macquarie Group
Australia
$3.48M +$1.86M +51,920 +136%
1 2
3
4 5

MDCO Hedge Fund Activity: Q4 2013 in Review

182 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2013, worth a combined $2.6B — up 6% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MDCO positions and 21 closed out — a net gain of 11 holders — while 64 added to existing stakes and 66 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $32.2M. The largest seller was PointState Capital, cutting an estimated $51.8M.

  • 182 institutional investors held Medicines Co (MDCO) as of Q4 2013, up from 172 in Q3 2013.
  • Funds reported $2.6B of Medicines Co stock for Q4 2013, up 6% quarter-over-quarter.
  • 32 funds opened new Medicines Co positions in Q4 2013 and 21 closed out, a net change of +11 holders.
  • The largest Medicines Co buyer in Q4 2013 was Frontier Capital Management, an estimated $32.2M added.
  • The largest Medicines Co seller in Q4 2013 was PointState Capital, an estimated $51.8M sold.

Based on aggregated 13F filings for Q4 2013.